Ukraine Sanctions Chief Heads to Washington to Push Russia Bill 
Dollar Holds Near Two-Week High as Fed Rate Hike Bets Rise 
OpenAI Nears Astra AI Model Launch With Safety Focus 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
Bank of England Sees Surge in Higher-Risk Collateral 
Asian Stocks Tumble as Oil Surge Fuels Rate Hike Fears 
Treasury Yields Set to Stay High as Debt Supply Pressures Bond Market 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Gold Prices Slide as Iran Conflict Fuels Fed Rate Hike Bets 
China Manufacturing PMI Contracts Again as Recovery Remains Fragile 
Bessent Urges Japan on Fiscal Discipline, BOJ Rate Hikes 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Global Markets Brace for Fed Rate Hike as Oil Tops $91 
German Retail Sales Drop 3.4% in July 
Add as a preferred source on Google
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
